StockNews.AI
SCPH
StockNews.AI
160 days

scPharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on Wednesday, March 19, 2025

1. scPharmaceuticals will host a conference call on March 19, 2025. 2. The call will discuss Q4 2024 and full year financial results. 3. The company focuses on patient-centric innovations in cardiorenal healthcare. 4. scPharmaceuticals aims to improve global health through integrated therapies. 5. Registration for the call is available via their investor relations website.

3m saved
Insight
Article

FAQ

Why Bullish?

The upcoming financial results could improve investor confidence, potentially driving the stock price up as seen in past earnings calls where positive results led to stock rallying.

How important is it?

The conference call will provide key insights into company performance, which is crucial for investors and can drive stock volatility based on outcomes.

Why Short Term?

The effects of the conference call will likely influence SCPH's stock price immediately surrounding the event, similar to immediate market reactions following previous earnings announcements.

Related Companies

SCPHPFEJNJAZN
Management to host conference call and webcast, after-market on March 19, 2025, at 4:30 p.m. ET March 12, 2025 16:01 ET  | Source: scPharmaceuticals Inc. BURLINGTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through patient-centric innovations, today announced that scPharmaceuticals management will host a conference call and audio webcast at 4:30 p.m. ET on Wednesday, March 19, 2025, to discuss the financial results for the fourth quarter and full year 2024, and provide a business update. Registration and access for the conference call can be completed through this direct registration link. The live webcast and replay of the conference call can be accessed here or under “News & Events” in the Investor Relations section of the Company’s website, www.scpharmaceuticals.com. About scPharmaceuticalsAt scPharmaceuticals, we are powered by passion, driven by patient care. Our Mission is focused on advancing cardiorenal care through innovative, integrated treatments that address unmet patient needs. Our goal is to become the foremost advocate for patient-centric cardiorenal care, driving global health improvements through specialized, multidisciplinary approaches. scPharmaceuticals is expanding its reach, offering integrated therapies and products that address diverse healthcare needs and potentially improve the lives of our patients. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com. Katherine MirandascPharmaceuticals Inc., 781-301-6869kmiranda@scpharma.com Investors:Nick ColangeloGilmartin Group, 339-225-1047Nick@GilmartinIR.com

Related News